Skip to content
  • Home
  • IOncology
  • Infectious Desease Frontier
  • IHepatology
  • Hematology Frontier
  • Conference topics
  • Experts Interviews
  • Informations
  • Live Broadcasting
  • Logout
MediaMedic

Connecting Medical Expertise through Media

  • Home
  • IOncology
  • Infectious Disease Frontier
  • International Hepatology
  • Hematology Frontier
  • Conference topics
  • Experts’ Interviews
  • Informations
  • Home
  • IOncology
  • Infectious Disease Frontier
  • International Hepatology
  • Hematology Frontier
  • Conference topics
  • Experts’ Interviews
  • Informations

Informations

Home » Informations
  • EBMT Roundtable Discussion | Professor Shaoyan Hu’s Team: Efficacy and Safety of Allo-HSCT and CAR-T Cell Therapy in Pediatric Leukemia Patients

    Allogeneic Hematopoietic Stem Cell Transplantation (allo-HSCT) and Chimeric Antigen Receptor T-cell (CAR-T) therapy have become crucial in the treatment of leukemia. However, the effectiveness and safety of these treatments continue to be hot topics of research. Recent breakthrough studies have provided valuable insights, particularly in the treatment of children with relapsed/refractory B-cell acute lymphoblastic leukemia…

    2024.05.22
  • Winstrol como tomar: Guía completa para aprovechar al máximo este esteroide

    Winstrol como tomar: Guía completa para aprovechar al máximo este esteroide Si estás buscando información sobre cómo tomar Winstrol de manera efectiva, has llegado al lugar indicado. En esta guía,…

    2024.05.22
  • Utilisation de Trenbolone: Ce que vous devez savoir

    Utilisation de Trenbolone: Ce que vous devez savoir L’utilisation de Trenbolone est une pratique courante parmi les culturistes et les athlètes à la recherche de gains musculaires significatifs. Cependant, il…

    2024.05.22
  • Todo lo que necesitas saber sobre el curso de Viagra

    Todo lo que necesitas saber sobre el curso de Viagra Si estás considerando tomar un curso de Viagra, es importante estar bien informado antes de tomar una decisión. Aquí encontrarás…

    2024.05.22
  • Expert Perspective|Professor Jinjun Chen on Non-Invasive Diagnosis of Portal Hypertension in Patients with Advanced Chronic Liver Disease

    Complications related to portal hypertension are the main cause of death in patients with advanced chronic liver disease (ACLD). Even after the underlying cause is controlled, clinical events during the progression of portal hypertension, such as esophageal variceal bleeding, ascites, overt hepatic encephalopathy, and acute-on-chronic liver failure, are the most critical factors leading to high…

    2024.05.21
  • test

    test test

    2024.05.21
  • From Inoperable to Surgical Resection——Transformative Treatments Bring New Hope for Advanced Liver Cancer Patients

    To help clinicians and researchers in the field of hepatology stay updated with academic knowledge and research trends, Hepatology Digest and the Journal of Clinical and Translational Hepatology (JCTH) jointly launched the “Journal Club” column. Every two weeks (Tuesday), one selected article is highlighted, focusing on key points or insights to improve clinical practice, inspire…

    2024.05.21
  • “CARTITUDE-2 Phase II Update: Cilta-cel for Multiple Myeloma Post 1-3 Prior Therapies or Early Relapse”

    From April 14 to 17, 2024, the 50th European Society for Blood and Marrow Transplantation (EBMT) Annual Meeting was grandly held in Glasgow, UK, a city renowned for its historical significance. This year marks the 50th anniversary of EBMT, and the event gathered leading figures in the field of hematopoietic stem cell transplantation and over…

    2024.05.21
«previous next»
Recent Posts
  • CSCO Global Perspectives | Professor Yi-Long Wu in Conversation with Professor Everett Vokes: Advances in MET-Amplified NSCLC—From Resistance Mechanism to Actionable Oncogenic Driver
  • CSCO 2026 | Celebrating Excellence in Oncology: Five Major Award Categories Announced at the CSCO Plenary Session
  • CSCO 2026 | Precision-Driven Treatment with Multidimensional Benefits: How Lunbotinib Fumarate Is Reshaping the Treatment Landscape for RET Fusion-Positive Advanced NSCLC
  • Building on Standardization, Leading Through Digital and Intelligent Innovation — CSCO President Professor Jinming Yu on the High-Quality Development of Oncology and Innovative Medicines in China
  • CSCO 2026 | Professor Xinghao Ai: Obrixtamig Plus First-Line Standard Therapy Shows Encouraging Efficacy in Extensive-Stage Small Cell Lung Cancer
Recent Comments
    Archives
    • October 2026
    • September 2026
    • August 2026
    • July 2026
    • June 2026
    • May 2026
    • April 2026
    • March 2026
    • February 2026
    • January 2026
    • December 2025
    • November 2025
    • October 2025
    • September 2025
    • August 2025
    • July 2025
    • June 2025
    • May 2025
    • April 2025
    • March 2025
    • February 2025
    • January 2025
    • December 2024
    • November 2024
    • October 2024
    • September 2024
    • August 2024
    • July 2024
    • June 2024
    • May 2024
    • April 2024
    • March 2024
    • February 2024
    • January 2024
    • December 2023
    • November 2023
    • October 2023
    • August 2023
    Categories
    • Artificial intelligence
    • Hematology Frontier
    • Infectious Disease Frontier
    • International Hepatology
    • IOncology
    • Live broadcasting
    • Uncategorized
    • UroStream
    • LinkedIn
    • Twitter
    • Mail
    Related Media:
    Copyright 2026 — MediaMedic. All rights reserved. Blogun WordPress Theme
    Paris, France
    Scroll to Top